RECCE PHARMACEUTICALS LTD - News & Media

3.57%

29.0¢

Market Cap $72.42M

Healthcare Biotechnology

An Emerging Global Leader in the New Generation of Anti-Infective Therapies. Recce... An Emerging Global Leader in the New Generation of Anti-Infective Therapies. Recce Pharmaceuticals Ltd (ASX:RCE) is an Australian based globally-focussed, biotechnology company engaged in the development and commercialisation of a new class of synthetic anti-infectives.More

Corporate Spotlight

An Emerging Global Leader in the New Generation of Anti-Infective Therapies. Recce Pharmaceuticals Ltd (ASX:RCE) is an Australian based globally-focussed, biotechnology company engaged in the development and commercialisation of a new class of synthetic anti-infectives.
View the full Corporate Spotlight

Recce accelerates commercialisation

Articles & Videos

Recce adds 20 more people to trial for R327G foot gel

Recce Pharmaceuticals Ltd has received Human Ethics Approval to add 20 more patients with diabetic foot infections to its clinical trial

1 day ago

Recce to raise $15.8M in trial funds through placement, entitlement offer

Recce Pharmaceuticals Ltd plans to raise $5 million through a Placement to a private investor in Australia, and an Entitlement Offer

10 Apr 2025 13:17 (AEST)

Recce finds foot gel to be efficacious in Phase II clinical trial

Recce Pharmaceuticals Ltd has taken positive results from its Phase II clinical trial into topic gel R327G.

17 Feb 2025 11:28 (AEDT)

'Significant' new milestone for Recce in clinical testing of skin infection gel

Recce Pharmaceuticals Ltd has seen its share price rise more than 1% as it completes dosing of all 30 participants

21 Jan 2025 15:07 (AEDT)

Recce Pharmaceuticals advances global reach with Indonesia’s approval for Phase 3 Diabetic Foot Infection Trial

Recce Pharmaceuticals Ltd has secured approval for a Phase 3 trial on its treatment candidate to treat diabetic foot infections

09 Dec 2024 10:18 (AEDT)

Complete patent protection for 2 Recce anti-infective treatments

Recce Pharmaceuticals Ltd (ASX:RCE) has ticked off completion of all patents for two of its key anti-infectives, with the Australian Patent Office granting @Patent Family 3’ status to RECCE 327 (R327) and RECCE 529 (R529).The latest patent @ which expires in 2037 @ covers the proc...

26 Nov 2024 10:07 (AEDT)

Recce scores $6.75M R&D rebate

Recce Pharmaceuticals (ASX: RCE) has received a cash refund of $6,751,176 Research and Development (R&D) Tax Incentive rebate from the Australian Taxation Office for FY24.

14 Nov 2024 16:29 (AEDT)

Recce reaches key dosing milestone in testing of skin infection gel

Recce Pharmaceuticals Ltd has successfully dosed 20 out of 30 participants in its Phase II trial to test the RECCE 327 gel for skin infections

05 Nov 2024 12:59 (AEDT)

Recce progresses testing of gel to treat bacterial skin infections

Recce Pharmaceuticals Ltd has reached an important milestone in testing of its R327G gel to treat bacterial skin infections

09 Oct 2024 14:58 (AEDT)

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Recce Pharmaceuticals (ASX:RCE) has been on a tear this year. It's developing anti-infective, R327, with clinical results across Diabetic Foot Infection, Acute Bacterial Skin & Skin Structure Infection, and, Urosepsis/UTIs which point to a potential commercial value proposition. It also has a recent key relationship in Indonesia.

02 Oct 2024 07:15 (AEST)

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 29.0¢		Change 0.010(3.57%)		Mkt cap ! $72.42M

Open	High	Low	Value	Volume
29.0¢	29.0¢	28.0¢	$33.07K	114.5K

Buyers (Bids)

No.	Vol.	Price($)
1	10000	28.5¢

Sellers (Offers)

Price($)	Vol.	No.
29.0¢	26762	1

View Market Depth

No.	Vol.	Price($)
1	10000	0.285
5	40307	0.280
2	12269	0.275
3	17000	0.270
2	39739	0.265

Price($)	Vol.	No.
0.290	26762	1
0.295	100000	1
0.300	135768	2
0.305	3278	1
0.320	13125	2

Last trade - 16.10pm 23/04/2025 (20 minute delay)

RCE (ASX) Chart